Full Text
PDB27 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE-2 DIABETES IN TURKEY- A LONG-TERM HEALTH ECONOMIC ANALYSIS

Abstract

Authors

D Bruhn S Malhan S Kavuncubasi J Smith-Palmer V Reed

Back to Volume 12, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×